{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T10:50:05Z","timestamp":1777719005750,"version":"3.51.4"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1093\/humrep\/dei104","type":"journal-article","created":{"date-parts":[[2005,7,9]],"date-time":"2005-07-09T00:00:45Z","timestamp":1120867245000},"page":"2396-2401","source":"Crossref","is-referenced-by-count":59,"title":["Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study"],"prefix":"10.1093","volume":"20","author":[{"given":"I.A.A.","family":"Penna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.R.B.","family":"Canella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"Silva de S\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Ferriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,7,8]]},"reference":[{"key":"key\n\t\t\t\t20171011125646_R1","doi-asserted-by":"crossref","unstructured":"Barbieri RL and Hornstein MD (1988) Hyperinsulinemia and ovarian hyperandrogenism: cause and effect. Endocrinol Metab Clin North Am17, 685\u2013703.","DOI":"10.1016\/S0889-8529(18)30405-5"},{"key":"key\n\t\t\t\t20171011125646_R2","doi-asserted-by":"crossref","unstructured":"Barbieri RL, Makris A and Ryan KJ (1983) Effects of insulin on steroidogenesis in cultured porcine ovarian theca. Fertil Steril40, 237\u2013241.","DOI":"10.1016\/S0015-0282(16)47243-2"},{"key":"key\n\t\t\t\t20171011125646_R3","doi-asserted-by":"crossref","unstructured":"Burghen GA, Givens JR and Kitabchi AE (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovary disease. J Clin Endocrinol Metab50, 113\u2013111.","DOI":"10.1210\/jcem-50-1-113"},{"key":"key\n\t\t\t\t20171011125646_R4","unstructured":"Calle-Pascual A, Garcia-Honduvilla J and Martin-Alvarez PJ (1996) Influence of 16-week monotherapy with acarbose on cardiovascular risk factors in obese subjects with non-insulin-dependent diabetes mellitus: a controlled, double-blind comparison study with placebo. Diabet Metab22, 201\u2013202."},{"key":"key\n\t\t\t\t20171011125646_R5","doi-asserted-by":"crossref","unstructured":"Carmina E and Lobo RA (1999) Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab84, 1897\u20131899.","DOI":"10.1210\/jcem.84.6.5803"},{"key":"key\n\t\t\t\t20171011125646_R6","doi-asserted-by":"crossref","unstructured":"Chiasson JL, Josse RG, Leiter LA, Mihic M, Nathan DM, Palmason C, Cohen RM and Wolever TM (1996) The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance. Diabet Care19, 1190\u20131193.","DOI":"10.2337\/diacare.19.11.1190"},{"key":"key\n\t\t\t\t20171011125646_R7","doi-asserted-by":"crossref","unstructured":"Ciotta L, Calogero AE, Farina M, De Leo V, La Marca A and Cianci A (2001) Clinical, endocrine and metabolic effects of acarbose, an \u03b1-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance. Hum Reprod16, 2066\u20132072.","DOI":"10.1093\/humrep\/16.10.2066"},{"key":"key\n\t\t\t\t20171011125646_R8","unstructured":"Coniff RF, Seaton TB, Shapiro JA, Robbins D, Kleinfield R, MacGill JB and Beisswenjer D (1996) Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. Diabet Care18, 817\u2013820."},{"key":"key\n\t\t\t\t20171011125646_R9","doi-asserted-by":"crossref","unstructured":"Dunaif A, Graf M, Mendeli J, Laumas V and Dobrjansky A (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia. J Clin Endocrinol Metab65, 499\u2013507.","DOI":"10.1210\/jcem-65-3-499"},{"key":"key\n\t\t\t\t20171011125646_R10","doi-asserted-by":"crossref","unstructured":"Dunaif A, Wu X and Lee A (2001) Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome. Am J Physiol Endocrinol Metab281, 392\u2013399.","DOI":"10.1152\/ajpendo.2001.281.2.E392"},{"key":"key\n\t\t\t\t20171011125646_R11","doi-asserted-by":"crossref","unstructured":"Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF and Sheirh Z (1992) Detection of functional ovarian hyperandrogenism in women with androgen excess. New Engl J Med327, 157\u2013162.","DOI":"10.1056\/NEJM199207163270304"},{"key":"key\n\t\t\t\t20171011125646_R12","doi-asserted-by":"crossref","unstructured":"Ferriman D and Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab21, 1440\u20131447.","DOI":"10.1210\/jcem-21-11-1440"},{"key":"key\n\t\t\t\t20171011125646_R13","doi-asserted-by":"crossref","unstructured":"Flier JS, Eastman RC, Minaker KJ, Matteson D and Rowe JW (1985) Acanthosis nigricans in obese women with hyperandrogenism: characterization of an insulin-resistant state distinct from type A and B syndrome. Diabetes34, 101\u2013107.","DOI":"10.2337\/diab.34.2.101"},{"key":"key\n\t\t\t\t20171011125646_R14","doi-asserted-by":"crossref","unstructured":"Franks S (1995) Polycystic ovary syndrome. New Engl J Med333, 853\u2013861.","DOI":"10.1056\/NEJM199509283331307"},{"key":"key\n\t\t\t\t20171011125646_R15","doi-asserted-by":"crossref","unstructured":"Garaulet M, Perez-Llamas F, Zamora S and Tebar FJ (2002) Interrelationship between serum lipid profile, serum hormones and other components of the metabolic syndrome. J Physiol Biochem58, 151\u2013160.","DOI":"10.1007\/BF03179852"},{"key":"key\n\t\t\t\t20171011125646_R16","doi-asserted-by":"crossref","unstructured":"Geisthovel F, Frorath B and Brabant G (1996) Acarbose reduces elevated testosterone serum concentration in hyperinsulinaemic premenopausal women: a pilot study. Hum Reprod11, 2377\u20132381.","DOI":"10.1093\/oxfordjournals.humrep.a019118"},{"key":"key\n\t\t\t\t20171011125646_R17","unstructured":"Gutzwiller JP (1997) Glucagon like peptide-1 is a physiologic regulator of food intake in humans. Gastroenterology112, a1153."},{"key":"key\n\t\t\t\t20171011125646_R18","unstructured":"Hanjalic-Beck A, Schories M, Reincke M, Kissel C and Karck U (2004) Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomized double-blind study. Hum Reprod19 (Suppl 1), 44."},{"key":"key\n\t\t\t\t20171011125646_R19","doi-asserted-by":"crossref","unstructured":"Harbone L, Fleming R, Lyall H and Sattar N (2003) Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet361, 1894\u20131901.","DOI":"10.1016\/S0140-6736(03)13493-9"},{"key":"key\n\t\t\t\t20171011125646_R20","doi-asserted-by":"crossref","unstructured":"Hanefeld M, Fischer S and Schulze J (1991) Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabet Care14, 732\u2013737.","DOI":"10.2337\/diacare.14.8.732"},{"key":"key\n\t\t\t\t20171011125646_R21","doi-asserted-by":"crossref","unstructured":"Hergenc G, Schulte H, Assmann G and Von Eckardstein A (1999) Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals. Atherosclerosis145, 147\u2013156.","DOI":"10.1016\/S0021-9150(99)00027-1"},{"key":"key\n\t\t\t\t20171011125646_R22","doi-asserted-by":"crossref","unstructured":"Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P and Martin MM (1976) The syndromes of insulin resistance and acanthosis nigricans. New Engl J Med294, 739\u2013745.","DOI":"10.1056\/NEJM197604012941401"},{"key":"key\n\t\t\t\t20171011125646_R23","unstructured":"Kahn CR, Prigeon RL and McCulloch DK (1993) Qualification of the relationship between insulin sensitivity and \u03b2-cell function in human subjects. Evidence for a hyperbolic function. Diabetes42, 1663\u20131672."},{"key":"key\n\t\t\t\t20171011125646_R24","doi-asserted-by":"crossref","unstructured":"Kido Y, Nakae J and Accili D (2001) The insulin receptor and its cellular targets. J Clin Endocrinol Metab86, 972\u2013979.","DOI":"10.1210\/jc.86.3.972"},{"key":"key\n\t\t\t\t20171011125646_R25","doi-asserted-by":"crossref","unstructured":"Kosaka K, Kuzuya T, Hagura R and Yoshimga H (1996) Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet Med13, 109\u2013119.","DOI":"10.1002\/dme.1996.13.s6.109"},{"key":"key\n\t\t\t\t20171011125646_R26","doi-asserted-by":"crossref","unstructured":"Laube H (2002) Acarbose. Clin Drug Invest22, 141\u2013156.","DOI":"10.2165\/00044011-200222030-00001"},{"key":"key\n\t\t\t\t20171011125646_R27","doi-asserted-by":"crossref","unstructured":"Legro RS, Kuselman AR and Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab84, 165\u2013169.","DOI":"10.1097\/00006254-199906000-00019"},{"key":"key\n\t\t\t\t20171011125646_R28","doi-asserted-by":"crossref","unstructured":"Leo V, Marca A and Petraglia F (2003) Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev24, 633\u2013667.","DOI":"10.1210\/er.2002-0015"},{"key":"key\n\t\t\t\t20171011125646_R29","doi-asserted-by":"crossref","unstructured":"Lindstr\u00f6m J, Tuomilehto J and Spengler M (2000) Acarbose treatment does not change the habitual diet of patients with type 2 diabetes mellitus. Diabet Med17, 1612\u20131618.","DOI":"10.1046\/j.1464-5491.2000.00210.x"},{"key":"key\n\t\t\t\t20171011125646_R30","doi-asserted-by":"crossref","unstructured":"Lord JM, Flight IHK and Norman RJ (2003) Metformin in polycystic ovary syndrome: systematic review and meta-analysis. Br Med J327, 1\u20136.","DOI":"10.1136\/bmj.327.7421.951"},{"key":"key\n\t\t\t\t20171011125646_R31","doi-asserted-by":"crossref","unstructured":"Lukanova A, Lundin E, Zeleniuch-Jacquotte A and Muti P (2004) Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol150, 161\u2013171.","DOI":"10.1530\/eje.0.1500161"},{"key":"key\n\t\t\t\t20171011125646_R32","doi-asserted-by":"crossref","unstructured":"Maciel GAR, Junior JMS, Motta ELA, Abi Haidas M, de Lima GR and Baracat EC (2004) Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin. Fertil Steril81, 355\u2013360.","DOI":"10.1016\/j.fertnstert.2003.08.012"},{"key":"key\n\t\t\t\t20171011125646_R33","doi-asserted-by":"crossref","unstructured":"Mertes G (2001) Safety and efficacy of acarbose in the treatment of type II diabetes. Data from a 5-year surveillance study. Diabet Res Clin Pract52, 193\u2013204.","DOI":"10.1016\/S0168-8227(01)00221-2"},{"key":"key\n\t\t\t\t20171011125646_R34","unstructured":"Metwally MS (2004) The use of metformin in women with polycystic ovary syndrome: how effective is it? Hum Reprod19 (Suppl 1), 45."},{"key":"key\n\t\t\t\t20171011125646_R35","doi-asserted-by":"crossref","unstructured":"Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Martikainen HK and Tapanainen JS (2000) Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab85, 3161\u20133168.","DOI":"10.1210\/jc.85.9.3161"},{"key":"key\n\t\t\t\t20171011125646_R36","unstructured":"M\u00fcller L (1985) Microbial glycosidase inhibitor. Biotechnology18, 2\u201337."},{"key":"key\n\t\t\t\t20171011125646_R37","unstructured":"National Institute of Health (2000) The Practical Guide: Identification, Evaluation and Treatment of Overweight and Obesity in Adults. In National Heart, Lung and Blood Institute North American Association for Study of Obesity. National Institute of Health, Bethesda, MD, pp. 1\u201324."},{"key":"key\n\t\t\t\t20171011125646_R38","doi-asserted-by":"crossref","unstructured":"Nestler JE and Jakubowicz DJ (1996) Decreases in ovarian cytochrome p450c17 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. New Engl J Med335, 617\u2013623.","DOI":"10.1056\/NEJM199608293350902"},{"key":"key\n\t\t\t\t20171011125646_R39","doi-asserted-by":"crossref","unstructured":"Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M and Morselli-Labate AM (2000) Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab85, 2767\u20132774.","DOI":"10.1210\/jcem.85.8.6738"},{"key":"key\n\t\t\t\t20171011125646_R40","doi-asserted-by":"crossref","unstructured":"Rachamani R, Bar-Dayan Y and Ronen Z (2004) The effect of acarbose on insulin resistance in obese, hypertensive subjects with normal glucose tolerance: randomized controlled study. Diabet Obes Metab6, 63\u201368.","DOI":"10.1111\/j.1463-1326.2004.00317.x"},{"key":"key\n\t\t\t\t20171011125646_R41","unstructured":"Rajesh S, Moody LO and Landgrebe SC (1982) Sex-hormone-binding globulin in clinically hyperandrogenic women: association of plasma concentration with body weight. Fertil Steril2, 207\u2013211."},{"key":"key\n\t\t\t\t20171011125646_R42","doi-asserted-by":"crossref","unstructured":"Rajkhowa M, Bicknel J, Jones M and Clayton RN (1994) Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia. Fertil Steril61, 605\u2013612.","DOI":"10.1016\/S0015-0282(16)56633-3"},{"key":"key\n\t\t\t\t20171011125646_R43","doi-asserted-by":"crossref","unstructured":"Reis RM, Foss MC, Dias de Moura M and Ferriani RA (1995) Insulin secretion in obese and non-obese women with polycystic ovary syndrome and relationship with hyperandrogenism. Gynecol Endocrinol9, 45\u201350.","DOI":"10.3109\/09513599509160190"},{"key":"key\n\t\t\t\t20171011125646_R44","unstructured":"Rodier M, Richard JL, Monnier L and Mirauze J (1988) Effect of long term acarbose (Bay g 5421) therapy on metabolic control on non-insulin-dependent (type II) diabetes mellitus. Diabet Met14, 12\u201314."},{"key":"key\n\t\t\t\t20171011125646_R45","unstructured":"Santeusanio F, Ventura MM and Contadinbi S (1993) Efficacy and safety of two different dosages of acarbose in non-insulin dependent diabetic patients treated by diet alone. Diabet Nutr Metab6, 147\u2013154."},{"key":"key\n\t\t\t\t20171011125646_R46","unstructured":"Scheen AJ (1998) Clinical efficacy of acarbose in diabetes mellitus: critical review of controlled trials. Diabet Metab24, 311\u2013320."},{"key":"key\n\t\t\t\t20171011125646_R47","doi-asserted-by":"crossref","unstructured":"Siiteri PK and Simberg NH (1986) Changing concepts of active androgens in blood. Clin Endocrinol Metab15, 247\u2013258.","DOI":"10.1016\/S0300-595X(86)80023-8"},{"key":"key\n\t\t\t\t20171011125646_R48","doi-asserted-by":"crossref","unstructured":"S\u00f6nmez AS, Yaar L, Savan K, Ko\u00e7 S, \u00d6zcan J, Toklar A, Yazcolu F, Akg\u00fcn A and Sut N (2005) Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome. Hum Reprod20, 175\u2013179.","DOI":"10.1093\/humrep\/deh580"},{"key":"key\n\t\t\t\t20171011125646_R49","unstructured":"Stuart CA, Prince MJ, Peters EJ and Meyer WJ III (1987) Hyperinsulinemia and hyperandrogenemia: in vivo androgen response to insulin infusion. Obstet Gynecol69, 921\u2013925."},{"key":"key\n\t\t\t\t20171011125646_R50","doi-asserted-by":"crossref","unstructured":"Taylor SI, Dons RF, Hernandez E, Roth J and Gorden P (1982) Insulin resistance associated with androgen excess in women with auto-antibodies to the insulin receptor. Am Inter Med97, 851\u2013855.","DOI":"10.7326\/0003-4819-97-6-851"},{"key":"key\n\t\t\t\t20171011125646_R52","doi-asserted-by":"crossref","unstructured":"Wareham NJ, Phillips DL and Byrne CD (1995) The 30\u2009minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion (letter; comment). Diabet Med12, 931.","DOI":"10.1111\/j.1464-5491.1995.tb00399.x"},{"key":"key\n\t\t\t\t20171011125646_R53","doi-asserted-by":"crossref","unstructured":"Wolever TMS, Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA and Tan MH (1998) No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30\u201360% of energy from carbohydrate. Diabet Care21, 1612\u20131618.","DOI":"10.2337\/diacare.21.10.1612"},{"key":"key\n\t\t\t\t20171011125646_R54","doi-asserted-by":"crossref","unstructured":"Young DS (1968) Implementation of SI units for clinical laboratory data. Ann Intern Med106, 114\u2013129.","DOI":"10.7326\/0003-4819-106-1-114"},{"key":"key\n\t\t\t\t20171011125646_R55","unstructured":"Zawadski JK and Dunaif A (1992) Diagnostic criteria of polycystic ovary syndrome: towards a rational approach. In Dunaif A, Givens JR, Haseltine FP, and Merriam R (eds) Polycystic Ovary Syndrome. Blackwell Scientific, Boston, pp. 377\u2013384."}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/20\/9\/2396\/6954049\/dei104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T17:30:56Z","timestamp":1551807056000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/20\/9\/2396\/2356843\/Acarbose-in-obese-patients-with-polycystic-ovarian"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,8]]},"references-count":54,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2005,7,8]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dei104","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,9]]},"published":{"date-parts":[[2005,7,8]]}}}